Global Biciruizumab Supply, Demand and Key Producers, 2026-2032
The global Biciruizumab market size is expected to reach $ 8879 million by 2032, rising at a market growth of 14.6% CAGR during the forecast period (2026-2032).
Bevacizumab is a recombinant humanized monoclonal antibody primarily used for the treatment of various types of cancer, including colorectal cancer, non-small cell lung cancer, and renal cell carcinoma. It works by targeting and inhibiting the action of vascular endothelial growth factor (VEGF), preventing the formation of new blood vessels in tumors, thus reducing tumor blood supply and inhibiting tumor growth and spread. Bevacizumab is widely used in combination cancer therapies, typically in conjunction with chemotherapy or other targeted drugs to enhance therapeutic efficacy. The drug is administered intravenously and has been approved for clinical use in multiple countries and regions.In 2025, global Bimekizumab production reached approximately 1.2 million vials.
Bevacizumab holds an important position in the global cancer drug market, especially in the treatment of various solid tumors, such as colorectal cancer, non-small cell lung cancer, and renal cell carcinoma. With the continuous rise in cancer prevalence and ongoing innovations in cancer treatment, the market demand for Bevacizumab is steadily increasing. This drug works by inhibiting vascular endothelial growth factor (VEGF), blocking tumor angiogenesis, and significantly improving treatment outcomes, particularly when used in combination with chemotherapy and other targeted therapies. The market prospects for Bevacizumab are very promising, particularly in developing countries and emerging markets, where improvements in healthcare infrastructure and the widespread adoption of cancer screening will benefit more patients. Although Bevacizumab is priced relatively high and faces competition from generic drugs, it remains a core component of many cancer treatment regimens. Additionally, as research into Bevacizumab’s use in other cancer types continues to expand, it is expected that the drug’s indications will continue to grow, further driving market growth.
This report studies the global Biciruizumab production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biciruizumab and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biciruizumab that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biciruizumab total production and demand, 2021-2032, (Units)
Global Biciruizumab total production value, 2021-2032, (USD Million)
Global Biciruizumab production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Biciruizumab consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Biciruizumab domestic production, consumption, key domestic manufacturers and share
Global Biciruizumab production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Biciruizumab production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Biciruizumab production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Biciruizumab market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Chugai Pharmaceutical, Amgen, Pfizer, Qilu Pharmaceutical, Innovent Biologics, Jiangsu Hengrui Medicine, Shandong Boan Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biciruizumab market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Biciruizumab Market, By Region:
1. How big is the global Biciruizumab market?
2. What is the demand of the global Biciruizumab market?
3. What is the year over year growth of the global Biciruizumab market?
4. What is the production and production value of the global Biciruizumab market?
5. Who are the key producers in the global Biciruizumab market?
6. What are the growth factors driving the market demand?
Bevacizumab is a recombinant humanized monoclonal antibody primarily used for the treatment of various types of cancer, including colorectal cancer, non-small cell lung cancer, and renal cell carcinoma. It works by targeting and inhibiting the action of vascular endothelial growth factor (VEGF), preventing the formation of new blood vessels in tumors, thus reducing tumor blood supply and inhibiting tumor growth and spread. Bevacizumab is widely used in combination cancer therapies, typically in conjunction with chemotherapy or other targeted drugs to enhance therapeutic efficacy. The drug is administered intravenously and has been approved for clinical use in multiple countries and regions.In 2025, global Bimekizumab production reached approximately 1.2 million vials.
Bevacizumab holds an important position in the global cancer drug market, especially in the treatment of various solid tumors, such as colorectal cancer, non-small cell lung cancer, and renal cell carcinoma. With the continuous rise in cancer prevalence and ongoing innovations in cancer treatment, the market demand for Bevacizumab is steadily increasing. This drug works by inhibiting vascular endothelial growth factor (VEGF), blocking tumor angiogenesis, and significantly improving treatment outcomes, particularly when used in combination with chemotherapy and other targeted therapies. The market prospects for Bevacizumab are very promising, particularly in developing countries and emerging markets, where improvements in healthcare infrastructure and the widespread adoption of cancer screening will benefit more patients. Although Bevacizumab is priced relatively high and faces competition from generic drugs, it remains a core component of many cancer treatment regimens. Additionally, as research into Bevacizumab’s use in other cancer types continues to expand, it is expected that the drug’s indications will continue to grow, further driving market growth.
This report studies the global Biciruizumab production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biciruizumab and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biciruizumab that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biciruizumab total production and demand, 2021-2032, (Units)
Global Biciruizumab total production value, 2021-2032, (USD Million)
Global Biciruizumab production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Biciruizumab consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Biciruizumab domestic production, consumption, key domestic manufacturers and share
Global Biciruizumab production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Biciruizumab production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Biciruizumab production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Biciruizumab market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Chugai Pharmaceutical, Amgen, Pfizer, Qilu Pharmaceutical, Innovent Biologics, Jiangsu Hengrui Medicine, Shandong Boan Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biciruizumab market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Biciruizumab Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 100 mg/4 mL
- 320 mg/2 mL
- Bimekizumab In Combination With Methotrexate
- Bimekizumab Combined With Topical Corticosteroids
- Hospital
- Retail
- Online
- Intravenous Injection
- Subcutaneous Injection
- Psoriasis
- Ankylosing Spondylitis
- Hidradenitis Suppurativa
- Others
- Roche
- Chugai Pharmaceutical
- Amgen
- Pfizer
- Qilu Pharmaceutical
- Innovent Biologics
- Jiangsu Hengrui Medicine
- Shandong Boan Biotechnology
1. How big is the global Biciruizumab market?
2. What is the demand of the global Biciruizumab market?
3. What is the year over year growth of the global Biciruizumab market?
4. What is the production and production value of the global Biciruizumab market?
5. Who are the key producers in the global Biciruizumab market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Biciruizumab Introduction
1.2 World Biciruizumab Supply & Forecast
1.2.1 World Biciruizumab Production Value (2021 & 2025 & 2032)
1.2.2 World Biciruizumab Production (2021-2032)
1.2.3 World Biciruizumab Pricing Trends (2021-2032)
1.3 World Biciruizumab Production by Region (Based on Production Site)
1.3.1 World Biciruizumab Production Value by Region (2021-2032)
1.3.2 World Biciruizumab Production by Region (2021-2032)
1.3.3 World Biciruizumab Average Price by Region (2021-2032)
1.3.4 North America Biciruizumab Production (2021-2032)
1.3.5 Europe Biciruizumab Production (2021-2032)
1.3.6 China Biciruizumab Production (2021-2032)
1.3.7 Japan Biciruizumab Production (2021-2032)
1.3.8 India Biciruizumab Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biciruizumab Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biciruizumab Major Market Trends
2 DEMAND SUMMARY
2.1 World Biciruizumab Demand (2021-2032)
2.2 World Biciruizumab Consumption by Region
2.2.1 World Biciruizumab Consumption by Region (2021-2026)
2.2.2 World Biciruizumab Consumption Forecast by Region (2027-2032)
2.3 United States Biciruizumab Consumption (2021-2032)
2.4 China Biciruizumab Consumption (2021-2032)
2.5 Europe Biciruizumab Consumption (2021-2032)
2.6 Japan Biciruizumab Consumption (2021-2032)
2.7 South Korea Biciruizumab Consumption (2021-2032)
2.8 ASEAN Biciruizumab Consumption (2021-2032)
2.9 India Biciruizumab Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Biciruizumab Production Value by Manufacturer (2021-2026)
3.2 World Biciruizumab Production by Manufacturer (2021-2026)
3.3 World Biciruizumab Average Price by Manufacturer (2021-2026)
3.4 Biciruizumab Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Biciruizumab Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Biciruizumab in 2025
3.5.3 Global Concentration Ratios (CR8) for Biciruizumab in 2025
3.6 Biciruizumab Market: Overall Company Footprint Analysis
3.6.1 Biciruizumab Market: Region Footprint
3.6.2 Biciruizumab Market: Company Product Type Footprint
3.6.3 Biciruizumab Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Biciruizumab Production Value Comparison
4.1.1 United States VS China: Biciruizumab Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Biciruizumab Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Biciruizumab Production Comparison
4.2.1 United States VS China: Biciruizumab Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Biciruizumab Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Biciruizumab Consumption Comparison
4.3.1 United States VS China: Biciruizumab Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Biciruizumab Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Biciruizumab Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Biciruizumab Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Biciruizumab Production Value (2021-2026)
4.4.3 United States Based Manufacturers Biciruizumab Production (2021-2026)
4.5 China Based Biciruizumab Manufacturers and Market Share
4.5.1 China Based Biciruizumab Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Biciruizumab Production Value (2021-2026)
4.5.3 China Based Manufacturers Biciruizumab Production (2021-2026)
4.6 Rest of World Based Biciruizumab Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Biciruizumab Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Biciruizumab Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Biciruizumab Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Biciruizumab Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 100 mg/4 mL
5.2.2 320 mg/2 mL
5.3 Market Segment by Type
5.3.1 World Biciruizumab Production by Type (2021-2032)
5.3.2 World Biciruizumab Production Value by Type (2021-2032)
5.3.3 World Biciruizumab Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SPECIFICATION
6.1 World Biciruizumab Market Size Overview by Specification: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Specification
6.2.1 Bimekizumab In Combination With Methotrexate
6.2.2 Bimekizumab Combined With Topical Corticosteroids
6.3 Market Segment by Specification
6.3.1 World Biciruizumab Production by Specification (2021-2032)
6.3.2 World Biciruizumab Production Value by Specification (2021-2032)
6.3.3 World Biciruizumab Average Price by Specification (2021-2032)
7 MARKET ANALYSIS BY SALES CHANNELS
7.1 World Biciruizumab Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sales Channels
7.2.1 Hospital
7.2.2 Retail
7.2.3 Online
7.3 Market Segment by Sales Channels
7.3.1 World Biciruizumab Production by Sales Channels (2021-2032)
7.3.2 World Biciruizumab Production Value by Sales Channels (2021-2032)
7.3.3 World Biciruizumab Average Price by Sales Channels (2021-2032)
8 MARKET ANALYSIS BY DOSAGE FORM
8.1 World Biciruizumab Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Dosage Form
8.2.1 Intravenous Injection
8.2.2 Subcutaneous Injection
8.3 Market Segment by Dosage Form
8.3.1 World Biciruizumab Production by Dosage Form (2021-2032)
8.3.2 World Biciruizumab Production Value by Dosage Form (2021-2032)
8.3.3 World Biciruizumab Average Price by Dosage Form (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Biciruizumab Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Psoriasis
9.2.2 Ankylosing Spondylitis
9.2.3 Hidradenitis Suppurativa
9.2.4 Others
9.3 Market Segment by Application
9.3.1 World Biciruizumab Production by Application (2021-2032)
9.3.2 World Biciruizumab Production Value by Application (2021-2032)
9.3.3 World Biciruizumab Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Roche
10.1.1 Roche Details
10.1.2 Roche Major Business
10.1.3 Roche Biciruizumab Product and Services
10.1.4 Roche Biciruizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Roche Recent Developments/Updates
10.1.6 Roche Competitive Strengths & Weaknesses
10.2 Chugai Pharmaceutical
10.2.1 Chugai Pharmaceutical Details
10.2.2 Chugai Pharmaceutical Major Business
10.2.3 Chugai Pharmaceutical Biciruizumab Product and Services
10.2.4 Chugai Pharmaceutical Biciruizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Chugai Pharmaceutical Recent Developments/Updates
10.2.6 Chugai Pharmaceutical Competitive Strengths & Weaknesses
10.3 Amgen
10.3.1 Amgen Details
10.3.2 Amgen Major Business
10.3.3 Amgen Biciruizumab Product and Services
10.3.4 Amgen Biciruizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Amgen Recent Developments/Updates
10.3.6 Amgen Competitive Strengths & Weaknesses
10.4 Pfizer
10.4.1 Pfizer Details
10.4.2 Pfizer Major Business
10.4.3 Pfizer Biciruizumab Product and Services
10.4.4 Pfizer Biciruizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Pfizer Recent Developments/Updates
10.4.6 Pfizer Competitive Strengths & Weaknesses
10.5 Qilu Pharmaceutical
10.5.1 Qilu Pharmaceutical Details
10.5.2 Qilu Pharmaceutical Major Business
10.5.3 Qilu Pharmaceutical Biciruizumab Product and Services
10.5.4 Qilu Pharmaceutical Biciruizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Qilu Pharmaceutical Recent Developments/Updates
10.5.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
10.6 Innovent Biologics
10.6.1 Innovent Biologics Details
10.6.2 Innovent Biologics Major Business
10.6.3 Innovent Biologics Biciruizumab Product and Services
10.6.4 Innovent Biologics Biciruizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Innovent Biologics Recent Developments/Updates
10.6.6 Innovent Biologics Competitive Strengths & Weaknesses
10.7 Jiangsu Hengrui Medicine
10.7.1 Jiangsu Hengrui Medicine Details
10.7.2 Jiangsu Hengrui Medicine Major Business
10.7.3 Jiangsu Hengrui Medicine Biciruizumab Product and Services
10.7.4 Jiangsu Hengrui Medicine Biciruizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Jiangsu Hengrui Medicine Recent Developments/Updates
10.7.6 Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
10.8 Shandong Boan Biotechnology
10.8.1 Shandong Boan Biotechnology Details
10.8.2 Shandong Boan Biotechnology Major Business
10.8.3 Shandong Boan Biotechnology Biciruizumab Product and Services
10.8.4 Shandong Boan Biotechnology Biciruizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 Shandong Boan Biotechnology Recent Developments/Updates
10.8.6 Shandong Boan Biotechnology Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Biciruizumab Industry Chain
11.2 Biciruizumab Upstream Analysis
11.2.1 Biciruizumab Core Raw Materials
11.2.2 Main Manufacturers of Biciruizumab Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Biciruizumab Production Mode
11.6 Biciruizumab Procurement Model
11.7 Biciruizumab Industry Sales Model and Sales Channels
11.7.1 Biciruizumab Sales Model
11.7.2 Biciruizumab Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Biciruizumab Introduction
1.2 World Biciruizumab Supply & Forecast
1.2.1 World Biciruizumab Production Value (2021 & 2025 & 2032)
1.2.2 World Biciruizumab Production (2021-2032)
1.2.3 World Biciruizumab Pricing Trends (2021-2032)
1.3 World Biciruizumab Production by Region (Based on Production Site)
1.3.1 World Biciruizumab Production Value by Region (2021-2032)
1.3.2 World Biciruizumab Production by Region (2021-2032)
1.3.3 World Biciruizumab Average Price by Region (2021-2032)
1.3.4 North America Biciruizumab Production (2021-2032)
1.3.5 Europe Biciruizumab Production (2021-2032)
1.3.6 China Biciruizumab Production (2021-2032)
1.3.7 Japan Biciruizumab Production (2021-2032)
1.3.8 India Biciruizumab Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biciruizumab Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biciruizumab Major Market Trends
2 DEMAND SUMMARY
2.1 World Biciruizumab Demand (2021-2032)
2.2 World Biciruizumab Consumption by Region
2.2.1 World Biciruizumab Consumption by Region (2021-2026)
2.2.2 World Biciruizumab Consumption Forecast by Region (2027-2032)
2.3 United States Biciruizumab Consumption (2021-2032)
2.4 China Biciruizumab Consumption (2021-2032)
2.5 Europe Biciruizumab Consumption (2021-2032)
2.6 Japan Biciruizumab Consumption (2021-2032)
2.7 South Korea Biciruizumab Consumption (2021-2032)
2.8 ASEAN Biciruizumab Consumption (2021-2032)
2.9 India Biciruizumab Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Biciruizumab Production Value by Manufacturer (2021-2026)
3.2 World Biciruizumab Production by Manufacturer (2021-2026)
3.3 World Biciruizumab Average Price by Manufacturer (2021-2026)
3.4 Biciruizumab Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Biciruizumab Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Biciruizumab in 2025
3.5.3 Global Concentration Ratios (CR8) for Biciruizumab in 2025
3.6 Biciruizumab Market: Overall Company Footprint Analysis
3.6.1 Biciruizumab Market: Region Footprint
3.6.2 Biciruizumab Market: Company Product Type Footprint
3.6.3 Biciruizumab Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Biciruizumab Production Value Comparison
4.1.1 United States VS China: Biciruizumab Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Biciruizumab Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Biciruizumab Production Comparison
4.2.1 United States VS China: Biciruizumab Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Biciruizumab Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Biciruizumab Consumption Comparison
4.3.1 United States VS China: Biciruizumab Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Biciruizumab Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Biciruizumab Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Biciruizumab Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Biciruizumab Production Value (2021-2026)
4.4.3 United States Based Manufacturers Biciruizumab Production (2021-2026)
4.5 China Based Biciruizumab Manufacturers and Market Share
4.5.1 China Based Biciruizumab Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Biciruizumab Production Value (2021-2026)
4.5.3 China Based Manufacturers Biciruizumab Production (2021-2026)
4.6 Rest of World Based Biciruizumab Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Biciruizumab Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Biciruizumab Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Biciruizumab Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Biciruizumab Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 100 mg/4 mL
5.2.2 320 mg/2 mL
5.3 Market Segment by Type
5.3.1 World Biciruizumab Production by Type (2021-2032)
5.3.2 World Biciruizumab Production Value by Type (2021-2032)
5.3.3 World Biciruizumab Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SPECIFICATION
6.1 World Biciruizumab Market Size Overview by Specification: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Specification
6.2.1 Bimekizumab In Combination With Methotrexate
6.2.2 Bimekizumab Combined With Topical Corticosteroids
6.3 Market Segment by Specification
6.3.1 World Biciruizumab Production by Specification (2021-2032)
6.3.2 World Biciruizumab Production Value by Specification (2021-2032)
6.3.3 World Biciruizumab Average Price by Specification (2021-2032)
7 MARKET ANALYSIS BY SALES CHANNELS
7.1 World Biciruizumab Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sales Channels
7.2.1 Hospital
7.2.2 Retail
7.2.3 Online
7.3 Market Segment by Sales Channels
7.3.1 World Biciruizumab Production by Sales Channels (2021-2032)
7.3.2 World Biciruizumab Production Value by Sales Channels (2021-2032)
7.3.3 World Biciruizumab Average Price by Sales Channels (2021-2032)
8 MARKET ANALYSIS BY DOSAGE FORM
8.1 World Biciruizumab Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Dosage Form
8.2.1 Intravenous Injection
8.2.2 Subcutaneous Injection
8.3 Market Segment by Dosage Form
8.3.1 World Biciruizumab Production by Dosage Form (2021-2032)
8.3.2 World Biciruizumab Production Value by Dosage Form (2021-2032)
8.3.3 World Biciruizumab Average Price by Dosage Form (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Biciruizumab Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Psoriasis
9.2.2 Ankylosing Spondylitis
9.2.3 Hidradenitis Suppurativa
9.2.4 Others
9.3 Market Segment by Application
9.3.1 World Biciruizumab Production by Application (2021-2032)
9.3.2 World Biciruizumab Production Value by Application (2021-2032)
9.3.3 World Biciruizumab Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Roche
10.1.1 Roche Details
10.1.2 Roche Major Business
10.1.3 Roche Biciruizumab Product and Services
10.1.4 Roche Biciruizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Roche Recent Developments/Updates
10.1.6 Roche Competitive Strengths & Weaknesses
10.2 Chugai Pharmaceutical
10.2.1 Chugai Pharmaceutical Details
10.2.2 Chugai Pharmaceutical Major Business
10.2.3 Chugai Pharmaceutical Biciruizumab Product and Services
10.2.4 Chugai Pharmaceutical Biciruizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Chugai Pharmaceutical Recent Developments/Updates
10.2.6 Chugai Pharmaceutical Competitive Strengths & Weaknesses
10.3 Amgen
10.3.1 Amgen Details
10.3.2 Amgen Major Business
10.3.3 Amgen Biciruizumab Product and Services
10.3.4 Amgen Biciruizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Amgen Recent Developments/Updates
10.3.6 Amgen Competitive Strengths & Weaknesses
10.4 Pfizer
10.4.1 Pfizer Details
10.4.2 Pfizer Major Business
10.4.3 Pfizer Biciruizumab Product and Services
10.4.4 Pfizer Biciruizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Pfizer Recent Developments/Updates
10.4.6 Pfizer Competitive Strengths & Weaknesses
10.5 Qilu Pharmaceutical
10.5.1 Qilu Pharmaceutical Details
10.5.2 Qilu Pharmaceutical Major Business
10.5.3 Qilu Pharmaceutical Biciruizumab Product and Services
10.5.4 Qilu Pharmaceutical Biciruizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Qilu Pharmaceutical Recent Developments/Updates
10.5.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
10.6 Innovent Biologics
10.6.1 Innovent Biologics Details
10.6.2 Innovent Biologics Major Business
10.6.3 Innovent Biologics Biciruizumab Product and Services
10.6.4 Innovent Biologics Biciruizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Innovent Biologics Recent Developments/Updates
10.6.6 Innovent Biologics Competitive Strengths & Weaknesses
10.7 Jiangsu Hengrui Medicine
10.7.1 Jiangsu Hengrui Medicine Details
10.7.2 Jiangsu Hengrui Medicine Major Business
10.7.3 Jiangsu Hengrui Medicine Biciruizumab Product and Services
10.7.4 Jiangsu Hengrui Medicine Biciruizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Jiangsu Hengrui Medicine Recent Developments/Updates
10.7.6 Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
10.8 Shandong Boan Biotechnology
10.8.1 Shandong Boan Biotechnology Details
10.8.2 Shandong Boan Biotechnology Major Business
10.8.3 Shandong Boan Biotechnology Biciruizumab Product and Services
10.8.4 Shandong Boan Biotechnology Biciruizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 Shandong Boan Biotechnology Recent Developments/Updates
10.8.6 Shandong Boan Biotechnology Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Biciruizumab Industry Chain
11.2 Biciruizumab Upstream Analysis
11.2.1 Biciruizumab Core Raw Materials
11.2.2 Main Manufacturers of Biciruizumab Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Biciruizumab Production Mode
11.6 Biciruizumab Procurement Model
11.7 Biciruizumab Industry Sales Model and Sales Channels
11.7.1 Biciruizumab Sales Model
11.7.2 Biciruizumab Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Biciruizumab Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Biciruizumab Production Value by Region (2021-2026) & (USD Million)
Table 3. World Biciruizumab Production Value by Region (2027-2032) & (USD Million)
Table 4. World Biciruizumab Production Value Market Share by Region (2021-2026)
Table 5. World Biciruizumab Production Value Market Share by Region (2027-2032)
Table 6. World Biciruizumab Production by Region (2021-2026) & (Units)
Table 7. World Biciruizumab Production by Region (2027-2032) & (Units)
Table 8. World Biciruizumab Production Market Share by Region (2021-2026)
Table 9. World Biciruizumab Production Market Share by Region (2027-2032)
Table 10. World Biciruizumab Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Biciruizumab Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Biciruizumab Major Market Trends
Table 13. World Biciruizumab Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Biciruizumab Consumption by Region (2021-2026) & (Units)
Table 15. World Biciruizumab Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Biciruizumab Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Biciruizumab Producers in 2025
Table 18. World Biciruizumab Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Biciruizumab Producers in 2025
Table 20. World Biciruizumab Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Biciruizumab Company Evaluation Quadrant
Table 22. World Biciruizumab Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Biciruizumab Production Site of Key Manufacturer
Table 24. Biciruizumab Market: Company Product Type Footprint
Table 25. Biciruizumab Market: Company Product Application Footprint
Table 26. Biciruizumab Competitive Factors
Table 27. Biciruizumab New Entrant and Capacity Expansion Plans
Table 28. Biciruizumab Mergers & Acquisitions Activity
Table 29. United States VS China Biciruizumab Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Biciruizumab Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Biciruizumab Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Biciruizumab Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Biciruizumab Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Biciruizumab Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Biciruizumab Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Biciruizumab Production Market Share (2021-2026)
Table 37. China Based Biciruizumab Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Biciruizumab Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Biciruizumab Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Biciruizumab Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Biciruizumab Production Market Share (2021-2026)
Table 42. Rest of World Based Biciruizumab Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Biciruizumab Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Biciruizumab Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Biciruizumab Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Biciruizumab Production Market Share (2021-2026)
Table 47. World Biciruizumab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Biciruizumab Production by Type (2021-2026) & (Units)
Table 49. World Biciruizumab Production by Type (2027-2032) & (Units)
Table 50. World Biciruizumab Production Value by Type (2021-2026) & (USD Million)
Table 51. World Biciruizumab Production Value by Type (2027-2032) & (USD Million)
Table 52. World Biciruizumab Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Biciruizumab Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Biciruizumab Production Value by Specification, (USD Million), 2021 & 2025 & 2032
Table 55. World Biciruizumab Production by Specification (2021-2026) & (Units)
Table 56. World Biciruizumab Production by Specification (2027-2032) & (Units)
Table 57. World Biciruizumab Production Value by Specification (2021-2026) & (USD Million)
Table 58. World Biciruizumab Production Value by Specification (2027-2032) & (USD Million)
Table 59. World Biciruizumab Average Price by Specification (2021-2026) & (US$/Unit)
Table 60. World Biciruizumab Average Price by Specification (2027-2032) & (US$/Unit)
Table 61. World Biciruizumab Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 62. World Biciruizumab Production by Sales Channels (2021-2026) & (Units)
Table 63. World Biciruizumab Production by Sales Channels (2027-2032) & (Units)
Table 64. World Biciruizumab Production Value by Sales Channels (2021-2026) & (USD Million)
Table 65. World Biciruizumab Production Value by Sales Channels (2027-2032) & (USD Million)
Table 66. World Biciruizumab Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 67. World Biciruizumab Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 68. World Biciruizumab Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 69. World Biciruizumab Production by Dosage Form (2021-2026) & (Units)
Table 70. World Biciruizumab Production by Dosage Form (2027-2032) & (Units)
Table 71. World Biciruizumab Production Value by Dosage Form (2021-2026) & (USD Million)
Table 72. World Biciruizumab Production Value by Dosage Form (2027-2032) & (USD Million)
Table 73. World Biciruizumab Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 74. World Biciruizumab Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 75. World Biciruizumab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Biciruizumab Production by Application (2021-2026) & (Units)
Table 77. World Biciruizumab Production by Application (2027-2032) & (Units)
Table 78. World Biciruizumab Production Value by Application (2021-2026) & (USD Million)
Table 79. World Biciruizumab Production Value by Application (2027-2032) & (USD Million)
Table 80. World Biciruizumab Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Biciruizumab Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Roche Basic Information, Manufacturing Base and Competitors
Table 83. Roche Major Business
Table 84. Roche Biciruizumab Product and Services
Table 85. Roche Biciruizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Roche Recent Developments/Updates
Table 87. Roche Competitive Strengths & Weaknesses
Table 88. Chugai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 89. Chugai Pharmaceutical Major Business
Table 90. Chugai Pharmaceutical Biciruizumab Product and Services
Table 91. Chugai Pharmaceutical Biciruizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Chugai Pharmaceutical Recent Developments/Updates
Table 93. Chugai Pharmaceutical Competitive Strengths & Weaknesses
Table 94. Amgen Basic Information, Manufacturing Base and Competitors
Table 95. Amgen Major Business
Table 96. Amgen Biciruizumab Product and Services
Table 97. Amgen Biciruizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Amgen Recent Developments/Updates
Table 99. Amgen Competitive Strengths & Weaknesses
Table 100. Pfizer Basic Information, Manufacturing Base and Competitors
Table 101. Pfizer Major Business
Table 102. Pfizer Biciruizumab Product and Services
Table 103. Pfizer Biciruizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Pfizer Recent Developments/Updates
Table 105. Pfizer Competitive Strengths & Weaknesses
Table 106. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 107. Qilu Pharmaceutical Major Business
Table 108. Qilu Pharmaceutical Biciruizumab Product and Services
Table 109. Qilu Pharmaceutical Biciruizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Qilu Pharmaceutical Recent Developments/Updates
Table 111. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 112. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 113. Innovent Biologics Major Business
Table 114. Innovent Biologics Biciruizumab Product and Services
Table 115. Innovent Biologics Biciruizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Innovent Biologics Recent Developments/Updates
Table 117. Innovent Biologics Competitive Strengths & Weaknesses
Table 118. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 119. Jiangsu Hengrui Medicine Major Business
Table 120. Jiangsu Hengrui Medicine Biciruizumab Product and Services
Table 121. Jiangsu Hengrui Medicine Biciruizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 123. Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
Table 124. Shandong Boan Biotechnology Basic Information, Manufacturing Base and Competitors
Table 125. Shandong Boan Biotechnology Major Business
Table 126. Shandong Boan Biotechnology Biciruizumab Product and Services
Table 127. Shandong Boan Biotechnology Biciruizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. Shandong Boan Biotechnology Recent Developments/Updates
Table 129. Shandong Boan Biotechnology Competitive Strengths & Weaknesses
Table 130. Global Key Players of Biciruizumab Upstream (Raw Materials)
Table 131. Global Biciruizumab Typical Customers
Table 132. Biciruizumab Typical Distributors
Table 1. World Biciruizumab Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Biciruizumab Production Value by Region (2021-2026) & (USD Million)
Table 3. World Biciruizumab Production Value by Region (2027-2032) & (USD Million)
Table 4. World Biciruizumab Production Value Market Share by Region (2021-2026)
Table 5. World Biciruizumab Production Value Market Share by Region (2027-2032)
Table 6. World Biciruizumab Production by Region (2021-2026) & (Units)
Table 7. World Biciruizumab Production by Region (2027-2032) & (Units)
Table 8. World Biciruizumab Production Market Share by Region (2021-2026)
Table 9. World Biciruizumab Production Market Share by Region (2027-2032)
Table 10. World Biciruizumab Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Biciruizumab Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Biciruizumab Major Market Trends
Table 13. World Biciruizumab Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Biciruizumab Consumption by Region (2021-2026) & (Units)
Table 15. World Biciruizumab Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Biciruizumab Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Biciruizumab Producers in 2025
Table 18. World Biciruizumab Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Biciruizumab Producers in 2025
Table 20. World Biciruizumab Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Biciruizumab Company Evaluation Quadrant
Table 22. World Biciruizumab Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Biciruizumab Production Site of Key Manufacturer
Table 24. Biciruizumab Market: Company Product Type Footprint
Table 25. Biciruizumab Market: Company Product Application Footprint
Table 26. Biciruizumab Competitive Factors
Table 27. Biciruizumab New Entrant and Capacity Expansion Plans
Table 28. Biciruizumab Mergers & Acquisitions Activity
Table 29. United States VS China Biciruizumab Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Biciruizumab Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Biciruizumab Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Biciruizumab Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Biciruizumab Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Biciruizumab Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Biciruizumab Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Biciruizumab Production Market Share (2021-2026)
Table 37. China Based Biciruizumab Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Biciruizumab Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Biciruizumab Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Biciruizumab Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Biciruizumab Production Market Share (2021-2026)
Table 42. Rest of World Based Biciruizumab Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Biciruizumab Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Biciruizumab Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Biciruizumab Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Biciruizumab Production Market Share (2021-2026)
Table 47. World Biciruizumab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Biciruizumab Production by Type (2021-2026) & (Units)
Table 49. World Biciruizumab Production by Type (2027-2032) & (Units)
Table 50. World Biciruizumab Production Value by Type (2021-2026) & (USD Million)
Table 51. World Biciruizumab Production Value by Type (2027-2032) & (USD Million)
Table 52. World Biciruizumab Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Biciruizumab Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Biciruizumab Production Value by Specification, (USD Million), 2021 & 2025 & 2032
Table 55. World Biciruizumab Production by Specification (2021-2026) & (Units)
Table 56. World Biciruizumab Production by Specification (2027-2032) & (Units)
Table 57. World Biciruizumab Production Value by Specification (2021-2026) & (USD Million)
Table 58. World Biciruizumab Production Value by Specification (2027-2032) & (USD Million)
Table 59. World Biciruizumab Average Price by Specification (2021-2026) & (US$/Unit)
Table 60. World Biciruizumab Average Price by Specification (2027-2032) & (US$/Unit)
Table 61. World Biciruizumab Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 62. World Biciruizumab Production by Sales Channels (2021-2026) & (Units)
Table 63. World Biciruizumab Production by Sales Channels (2027-2032) & (Units)
Table 64. World Biciruizumab Production Value by Sales Channels (2021-2026) & (USD Million)
Table 65. World Biciruizumab Production Value by Sales Channels (2027-2032) & (USD Million)
Table 66. World Biciruizumab Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 67. World Biciruizumab Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 68. World Biciruizumab Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 69. World Biciruizumab Production by Dosage Form (2021-2026) & (Units)
Table 70. World Biciruizumab Production by Dosage Form (2027-2032) & (Units)
Table 71. World Biciruizumab Production Value by Dosage Form (2021-2026) & (USD Million)
Table 72. World Biciruizumab Production Value by Dosage Form (2027-2032) & (USD Million)
Table 73. World Biciruizumab Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 74. World Biciruizumab Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 75. World Biciruizumab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Biciruizumab Production by Application (2021-2026) & (Units)
Table 77. World Biciruizumab Production by Application (2027-2032) & (Units)
Table 78. World Biciruizumab Production Value by Application (2021-2026) & (USD Million)
Table 79. World Biciruizumab Production Value by Application (2027-2032) & (USD Million)
Table 80. World Biciruizumab Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Biciruizumab Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Roche Basic Information, Manufacturing Base and Competitors
Table 83. Roche Major Business
Table 84. Roche Biciruizumab Product and Services
Table 85. Roche Biciruizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Roche Recent Developments/Updates
Table 87. Roche Competitive Strengths & Weaknesses
Table 88. Chugai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 89. Chugai Pharmaceutical Major Business
Table 90. Chugai Pharmaceutical Biciruizumab Product and Services
Table 91. Chugai Pharmaceutical Biciruizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Chugai Pharmaceutical Recent Developments/Updates
Table 93. Chugai Pharmaceutical Competitive Strengths & Weaknesses
Table 94. Amgen Basic Information, Manufacturing Base and Competitors
Table 95. Amgen Major Business
Table 96. Amgen Biciruizumab Product and Services
Table 97. Amgen Biciruizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Amgen Recent Developments/Updates
Table 99. Amgen Competitive Strengths & Weaknesses
Table 100. Pfizer Basic Information, Manufacturing Base and Competitors
Table 101. Pfizer Major Business
Table 102. Pfizer Biciruizumab Product and Services
Table 103. Pfizer Biciruizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Pfizer Recent Developments/Updates
Table 105. Pfizer Competitive Strengths & Weaknesses
Table 106. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 107. Qilu Pharmaceutical Major Business
Table 108. Qilu Pharmaceutical Biciruizumab Product and Services
Table 109. Qilu Pharmaceutical Biciruizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Qilu Pharmaceutical Recent Developments/Updates
Table 111. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 112. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 113. Innovent Biologics Major Business
Table 114. Innovent Biologics Biciruizumab Product and Services
Table 115. Innovent Biologics Biciruizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Innovent Biologics Recent Developments/Updates
Table 117. Innovent Biologics Competitive Strengths & Weaknesses
Table 118. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 119. Jiangsu Hengrui Medicine Major Business
Table 120. Jiangsu Hengrui Medicine Biciruizumab Product and Services
Table 121. Jiangsu Hengrui Medicine Biciruizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 123. Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
Table 124. Shandong Boan Biotechnology Basic Information, Manufacturing Base and Competitors
Table 125. Shandong Boan Biotechnology Major Business
Table 126. Shandong Boan Biotechnology Biciruizumab Product and Services
Table 127. Shandong Boan Biotechnology Biciruizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. Shandong Boan Biotechnology Recent Developments/Updates
Table 129. Shandong Boan Biotechnology Competitive Strengths & Weaknesses
Table 130. Global Key Players of Biciruizumab Upstream (Raw Materials)
Table 131. Global Biciruizumab Typical Customers
Table 132. Biciruizumab Typical Distributors
LIST OF FIGURES
Figure 1. Biciruizumab Picture
Figure 2. World Biciruizumab Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Biciruizumab Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Biciruizumab Production (2021-2032) & (Units)
Figure 5. World Biciruizumab Average Price (2021-2032) & (US$/Unit)
Figure 6. World Biciruizumab Production Value Market Share by Region (2021-2032)
Figure 7. World Biciruizumab Production Market Share by Region (2021-2032)
Figure 8. North America Biciruizumab Production (2021-2032) & (Units)
Figure 9. Europe Biciruizumab Production (2021-2032) & (Units)
Figure 10. China Biciruizumab Production (2021-2032) & (Units)
Figure 11. Japan Biciruizumab Production (2021-2032) & (Units)
Figure 12. India Biciruizumab Production (2021-2032) & (Units)
Figure 13. Biciruizumab Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biciruizumab Consumption (2021-2032) & (Units)
Figure 16. World Biciruizumab Consumption Market Share by Region (2021-2032)
Figure 17. United States Biciruizumab Consumption (2021-2032) & (Units)
Figure 18. China Biciruizumab Consumption (2021-2032) & (Units)
Figure 19. Europe Biciruizumab Consumption (2021-2032) & (Units)
Figure 20. Japan Biciruizumab Consumption (2021-2032) & (Units)
Figure 21. South Korea Biciruizumab Consumption (2021-2032) & (Units)
Figure 22. ASEAN Biciruizumab Consumption (2021-2032) & (Units)
Figure 23. India Biciruizumab Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Biciruizumab by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biciruizumab Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biciruizumab Markets in 2025
Figure 27. United States VS China: Biciruizumab Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Biciruizumab Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Biciruizumab Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Biciruizumab Production Market Share 2025
Figure 31. China Based Manufacturers Biciruizumab Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Biciruizumab Production Market Share 2025
Figure 33. World Biciruizumab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Biciruizumab Production Value Market Share by Type in 2025
Figure 35. 100 mg/4 mL
Figure 36. 320 mg/2 mL
Figure 37. World Biciruizumab Production Market Share by Type (2021-2032)
Figure 38. World Biciruizumab Production Value Market Share by Type (2021-2032)
Figure 39. World Biciruizumab Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Biciruizumab Production Value by Specification, (USD Million), 2021 & 2025 & 2032
Figure 41. World Biciruizumab Production Value Market Share by Specification in 2025
Figure 42. Bimekizumab In Combination With Methotrexate
Figure 43. Bimekizumab Combined With Topical Corticosteroids
Figure 44. World Biciruizumab Production Market Share by Specification (2021-2032)
Figure 45. World Biciruizumab Production Value Market Share by Specification (2021-2032)
Figure 46. World Biciruizumab Average Price by Specification (2021-2032) & (US$/Unit)
Figure 47. World Biciruizumab Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 48. World Biciruizumab Production Value Market Share by Sales Channels in 2025
Figure 49. Hospital
Figure 50. Retail
Figure 51. Online
Figure 52. World Biciruizumab Production Market Share by Sales Channels (2021-2032)
Figure 53. World Biciruizumab Production Value Market Share by Sales Channels (2021-2032)
Figure 54. World Biciruizumab Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 55. World Biciruizumab Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 56. World Biciruizumab Production Value Market Share by Dosage Form in 2025
Figure 57. Intravenous Injection
Figure 58. Subcutaneous Injection
Figure 59. World Biciruizumab Production Market Share by Dosage Form (2021-2032)
Figure 60. World Biciruizumab Production Value Market Share by Dosage Form (2021-2032)
Figure 61. World Biciruizumab Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 62. World Biciruizumab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World Biciruizumab Production Value Market Share by Application in 2025
Figure 64. Psoriasis
Figure 65. Ankylosing Spondylitis
Figure 66. Hidradenitis Suppurativa
Figure 67. Others
Figure 68. World Biciruizumab Production Market Share by Application (2021-2032)
Figure 69. World Biciruizumab Production Value Market Share by Application (2021-2032)
Figure 70. World Biciruizumab Average Price by Application (2021-2032) & (US$/Unit)
Figure 71. Biciruizumab Industry Chain
Figure 72. Biciruizumab Procurement Model
Figure 73. Biciruizumab Sales Model
Figure 74. Biciruizumab Sales Channels, Direct Sales, and Distribution
Figure 75. Methodology
Figure 76. Research Process and Data Source
Figure 1. Biciruizumab Picture
Figure 2. World Biciruizumab Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Biciruizumab Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Biciruizumab Production (2021-2032) & (Units)
Figure 5. World Biciruizumab Average Price (2021-2032) & (US$/Unit)
Figure 6. World Biciruizumab Production Value Market Share by Region (2021-2032)
Figure 7. World Biciruizumab Production Market Share by Region (2021-2032)
Figure 8. North America Biciruizumab Production (2021-2032) & (Units)
Figure 9. Europe Biciruizumab Production (2021-2032) & (Units)
Figure 10. China Biciruizumab Production (2021-2032) & (Units)
Figure 11. Japan Biciruizumab Production (2021-2032) & (Units)
Figure 12. India Biciruizumab Production (2021-2032) & (Units)
Figure 13. Biciruizumab Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biciruizumab Consumption (2021-2032) & (Units)
Figure 16. World Biciruizumab Consumption Market Share by Region (2021-2032)
Figure 17. United States Biciruizumab Consumption (2021-2032) & (Units)
Figure 18. China Biciruizumab Consumption (2021-2032) & (Units)
Figure 19. Europe Biciruizumab Consumption (2021-2032) & (Units)
Figure 20. Japan Biciruizumab Consumption (2021-2032) & (Units)
Figure 21. South Korea Biciruizumab Consumption (2021-2032) & (Units)
Figure 22. ASEAN Biciruizumab Consumption (2021-2032) & (Units)
Figure 23. India Biciruizumab Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Biciruizumab by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biciruizumab Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biciruizumab Markets in 2025
Figure 27. United States VS China: Biciruizumab Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Biciruizumab Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Biciruizumab Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Biciruizumab Production Market Share 2025
Figure 31. China Based Manufacturers Biciruizumab Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Biciruizumab Production Market Share 2025
Figure 33. World Biciruizumab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Biciruizumab Production Value Market Share by Type in 2025
Figure 35. 100 mg/4 mL
Figure 36. 320 mg/2 mL
Figure 37. World Biciruizumab Production Market Share by Type (2021-2032)
Figure 38. World Biciruizumab Production Value Market Share by Type (2021-2032)
Figure 39. World Biciruizumab Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Biciruizumab Production Value by Specification, (USD Million), 2021 & 2025 & 2032
Figure 41. World Biciruizumab Production Value Market Share by Specification in 2025
Figure 42. Bimekizumab In Combination With Methotrexate
Figure 43. Bimekizumab Combined With Topical Corticosteroids
Figure 44. World Biciruizumab Production Market Share by Specification (2021-2032)
Figure 45. World Biciruizumab Production Value Market Share by Specification (2021-2032)
Figure 46. World Biciruizumab Average Price by Specification (2021-2032) & (US$/Unit)
Figure 47. World Biciruizumab Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 48. World Biciruizumab Production Value Market Share by Sales Channels in 2025
Figure 49. Hospital
Figure 50. Retail
Figure 51. Online
Figure 52. World Biciruizumab Production Market Share by Sales Channels (2021-2032)
Figure 53. World Biciruizumab Production Value Market Share by Sales Channels (2021-2032)
Figure 54. World Biciruizumab Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 55. World Biciruizumab Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 56. World Biciruizumab Production Value Market Share by Dosage Form in 2025
Figure 57. Intravenous Injection
Figure 58. Subcutaneous Injection
Figure 59. World Biciruizumab Production Market Share by Dosage Form (2021-2032)
Figure 60. World Biciruizumab Production Value Market Share by Dosage Form (2021-2032)
Figure 61. World Biciruizumab Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 62. World Biciruizumab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World Biciruizumab Production Value Market Share by Application in 2025
Figure 64. Psoriasis
Figure 65. Ankylosing Spondylitis
Figure 66. Hidradenitis Suppurativa
Figure 67. Others
Figure 68. World Biciruizumab Production Market Share by Application (2021-2032)
Figure 69. World Biciruizumab Production Value Market Share by Application (2021-2032)
Figure 70. World Biciruizumab Average Price by Application (2021-2032) & (US$/Unit)
Figure 71. Biciruizumab Industry Chain
Figure 72. Biciruizumab Procurement Model
Figure 73. Biciruizumab Sales Model
Figure 74. Biciruizumab Sales Channels, Direct Sales, and Distribution
Figure 75. Methodology
Figure 76. Research Process and Data Source
